Dr. Wilson Liao is a Professor and Vice Chair of Research in the UCSF Department of Dermatology. He serves as Director of the UCSF Psoriasis and Skin Treatment Center and is deeply engaged in patient care, clinical trials, and translational research. The Liao Laboratory studies the genetics, immunology, and environmental triggers of psoriasis, atopic dermatitis, and hidradenitis suppurativa and uses machine learning and precision medicine approaches to advance dermatologic care. Dr. Liao directs the UCSF Psoriasis Research Initiative and Biobank with over 1,500 subjects, contributing to discovering over 30 psoriasis genes. He serves as Co-Principal Investigator of the NIH Accelerating Medicines Project Psoriatic Disease Team, leveraging single-cell and spatial profiling technologies to identify the cellular drivers of psoriasis. He co-founded Trex Bio, a biotechnology company developing novel therapeutics for inflammatory skin disease, and Solay, a telehealth company offering in-home therapy for psoriasis and eczema. Dr. Liao is also engaged in digital health initiatives and has developed SkinTracker, a mobile app allowing remote dermatology trials.
Areas of Interest
Genetics, genomics, immunology, precision medicine, digital health, biologic therapy, comorbidities, sleep, and environmental triggers
Involvement with Other Organization(s)
National Psoriasis Foundation, Medical Board; National Psoriasis Foundation, Scientific Advisory
Committee; Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), Co-Chair of Research Committee; Arthritis Foundation, Psoriatic Arthritis Expert Panel; Skin of Color